Schaper Benz Wise Investment Counsel Incwi Lowers stake in Stryker Corporation (SYK)

Stryker Corporation (SYK) : Schaper Benz Wise Investment Counsel Incwi reduced its stake in Stryker Corporation by 1.55% during the most recent quarter end. The investment management company now holds a total of 120,792 shares of Stryker Corporation which is valued at $13,869,337 after selling 1,905 shares in Stryker Corporation , the firm said in a disclosure report filed with the SEC on Aug 2, 2016.Stryker Corporation makes up approximately 2.44% of Schaper Benz Wise Investment Counsel Incwi’s portfolio.

Other Hedge Funds, Including , Mizuho Trust Banking Ltd. boosted its stake in SYK in the latest quarter, The investment management firm added 7,563 additional shares and now holds a total of 526,984 shares of Stryker Corporation which is valued at $60,508,303. Stryker Corporation makes up approx 0.18% of Mizuho Trust Banking Ltd.’s portfolio. Ftb Advisors added SYK to its portfolio by purchasing 69 company shares during the most recent quarter which is valued at $8,023. Brightworth added SYK to its portfolio by purchasing 1,763 company shares during the most recent quarter which is valued at $202,445. Stryker Corporation makes up approx 0.15% of Brightworth’s portfolio.Huntington National Bank boosted its stake in SYK in the latest quarter, The investment management firm added 42,423 additional shares and now holds a total of 158,939 shares of Stryker Corporation which is valued at $18,250,965. Stryker Corporation makes up approx 0.44% of Huntington National Bank’s portfolio.

Stryker Corporation closed down -0.08 points or -0.07% at $114.82 with 10,13,387 shares getting traded on Monday. Post opening the session at $114.99, the shares hit an intraday low of $114.07 and an intraday high of $115.07 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.

Investors should note that on Jul 27, 2016, Stryker Corporation announced a cash dividend of $0.3800. The company’s management has announced Sep 28, 2016 as the ex-dividend date and fixed the record date on Sep 30, 2016. The payable date has been fixed on Oct 31, 2016.

Many Wall Street Analysts have commented on Stryker Corporation. Stryker Corporation was Initiated by Guggenheim to “Buy” on Jun 9, 2016.

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Stryker Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Stryker Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.